Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1998-12-14
|
pubmed:abstractText |
An association between bipolar affective disorder and CAG/CTG trinucleotide repeat expansions (TRE) has previously been detected using the repeat expansion detection (RED) method. Here we report that 89% of RED products (CAG/CTG repeats) > 120 nt (n = 202) detected in affective disorder patients as well as unaffected family members and controls correlate with expansions at two repeat loci, ERDA1 on chromosome 17q21.3 and CTG18.1 on 18q21.1. In a set of patients and controls in which we had previously found a significant difference in RED size distribution, the frequency of expansions at the CTG18.1 locus was 13% in bipolar patients (n = 60) and 5% in controls (n = 114) (P < 0.07) with a significantly different size distribution (P < 0.03). A second set of patients were ascertained from 14 affective disorder families showing anticipation. Twelve of the families had members with RED products > 120 nt. The RED product distribution was significantly different (P < 0.0007) between affected (n = 53) and unaffected (n = 123) offspring. Using PCR, a higher frequency (P < 0.04) of CTG18.1 expansions as well as a different (P < 0.02) repeat size distribution was seen between affected and unaffected offspring. In addition, a negative correlation between RED product size and the age-of-onset could be seen in affected offspring (rs = -0.3, P = 0.05, n = 43). This effect was due to an earlier onset in individuals with long CTG18.1 expansions. No difference in ERDA1 expansion frequency was seen either between bipolar patients (35%, n = 60) and matched controls (29%, n = 114), or between affected and unaffected offspring in the families. We conclude that expanded alleles at the CTG18.1 locus confers an odds ratio of 2.6-2.8 and may thus act as a vulnerability factor for affective disorder, while the ERDA1 locus seems unrelated to disease.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1359-4184
|
pubmed:author |
pubmed-author:AdolfssonRR,
pubmed-author:BalciunieneJJ,
pubmed-author:BreschelTT,
pubmed-author:EngströmCC,
pubmed-author:LindbladKK,
pubmed-author:McInnisMM,
pubmed-author:NylanderP OPO,
pubmed-author:PetterssonUU,
pubmed-author:RoseC SCS,
pubmed-author:SchallingMM,
pubmed-author:StåhleLL,
pubmed-author:YuanQ PQP,
pubmed-author:ZanderCC
|
pubmed:issnType |
Print
|
pubmed:volume |
3
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
405-10
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9774773-Bipolar Disorder,
pubmed-meshheading:9774773-Chromosome Mapping,
pubmed-meshheading:9774773-Chromosomes, Human, Pair 17,
pubmed-meshheading:9774773-Chromosomes, Human, Pair 18,
pubmed-meshheading:9774773-Humans,
pubmed-meshheading:9774773-Mood Disorders,
pubmed-meshheading:9774773-Nuclear Family,
pubmed-meshheading:9774773-Sweden,
pubmed-meshheading:9774773-Trinucleotide Repeats
|
pubmed:year |
1998
|
pubmed:articleTitle |
Two commonly expanded CAG/CTG repeat loci: involvement in affective disorders?
|
pubmed:affiliation |
Department of Molecular Medicine, Karolinska Institute, Stockholm, Sweden.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|